Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $495.69 million. The enterprise value is $405.50 million.

Market Cap	495.69M
Enterprise Value	405.50M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 163.05 million shares outstanding. The number of shares has increased by 90.89% in one year.

Current Share Class	163.05M
Shares Outstanding	163.05M
Shares Change (YoY)	+90.89%
Shares Change (QoQ)	+6.90%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	50.11%
Float	142.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.28
P/TBV Ratio	4.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.26.

Current Ratio	2.95
Quick Ratio	2.81
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-76.47

Financial Efficiency

Return on equity (ROE) is -156.03% and return on invested capital (ROIC) is -80.06%.

Return on Equity (ROE)	-156.03%
Return on Assets (ROA)	-71.58%
Return on Invested Capital (ROIC)	-80.06%
Return on Capital Employed (ROCE)	-168.23%
Weighted Average Cost of Capital (WACC)	21.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	158
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.75% in the last 52 weeks. The beta is 3.23, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	3.23
52-Week Price Change	+71.75%
50-Day Moving Average	3.33
200-Day Moving Average	2.79
Relative Strength Index (RSI)	44.20
Average Volume (20 Days)	5,423,374

Short Selling Information

The latest short interest is 22.94 million, so 14.07% of the outstanding shares have been sold short.

Short Interest	22.94M
Short Previous Month	22.84M
Short % of Shares Out	14.07%
Short % of Float	16.06%
Short Ratio (days to cover)	4.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-179.40M
Pretax Income	-175.43M
Net Income	-175.43M
EBITDA	-177.90M
EBIT	-179.40M
Earnings Per Share (EPS)	-$1.84

Full Income Statement

Balance Sheet

The company has $116.64 million in cash and $26.45 million in debt, giving a net cash position of $90.19 million or $0.55 per share.

Cash & Cash Equivalents	116.64M
Total Debt	26.45M
Net Cash	90.19M
Net Cash Per Share	$0.55
Equity (Book Value)	103.31M
Book Value Per Share	0.93
Working Capital	80.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$142.84 million and capital expenditures -$444,000, giving a free cash flow of -$143.28 million.

Operating Cash Flow	-142.84M
Capital Expenditures	-444,000
Depreciation & Amortization	1.50M
Net Borrowing	-9.98M
Free Cash Flow	-143.28M
FCF Per Share	-$0.88

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-90.89%
Shareholder Yield	-90.89%
Earnings Yield	-35.39%
FCF Yield	-28.91%

Analyst Forecast

The average price target for Cabaletta Bio is $13.38, which is 340.13% higher than the current price. The consensus rating is "Buy".

Price Target	$13.38
Price Target Difference	340.13%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1